WHO WE ARE
BioGraph 55 is an immuno-oncology target discovery and drug development company. We leverage a proprietary spatial ‘omics’ platform called SPARTA to capture unique biological information that reflects clinical disease and is druggable. BioGraph 55 is discovering and developing therapies that target the underlying cellular interactomes that give rise to suppressive functional programs in tumors.
BioGraph 55, Inc.
455 Mission Bay Boulevard South
San Francisco, CA 94158
Copyright 2017 BioGraph 55, Inc.